Human breath gas analysis in the screening of gestational diabetes mellitus

Diabetes Technology and Therapeutics

Volumn 14, Issue 10, 2012, Pages 917-925

  Halbritter, Susanne ^a   Fedrigo, Mattia ^a   Höllriegl, Vera ^a   Szymczak, Wilfried ^a   Maier, Joerg M ^a,b,c   Ziegler, Anette Gabriele ^a,b,c   Hummel, Michael ^c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Diabetes Research Group EV   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; DIMETHYL SULFIDE; GLUCOSE; LIPID; METHANOL; THIOL; VOLATILE ORGANIC COMPOUND;

ARTICLE; BREATH ANALYSIS; BREATH GAS ANALYSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEASIBILITY STUDY; FEMALE; GLUCOSE OXIDATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPID OXIDATION; METABOLITE; NON INVASIVE MEASUREMENT; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPIC VARIATION; PILOT STUDY; PREDICTION; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; PROTON TRANSPORT; QUADRUPOLE MASS SPECTROMETRY; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; BREATH TESTS; DIABETES, GESTATIONAL; FASTING; FEASIBILITY STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; MASS SCREENING; MASS SPECTROMETRY; PHENOTYPE; PILOT PROJECTS; PREGNANCY; VOLATILE ORGANIC COMPOUNDS;

EID: 84867086252     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0076     Document Type: Article

References (39)

1. Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS: Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort. Diabetes Care 2005;28:579-584.
2. Kim C, Newton KM, Knopp RH: Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25:1862-1868.
3. Löbner K, Knopff A, Baumgarten A, Mollenhauer U, Marienfeld S, Garido-Franco M, Bonifacio E, Zieler AG: Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 2006;3:792-797.
4. Schaefer-Graf UM, Pawliczak J, Passow D, Hartmann R, Rossi R: Birth weight and parental BMI predict overweight in children from mothers with gestational diabetes. Diabetes Care 2005;28:1745-1750.
5. Phillips M, Herrera J, Krishnan S, Zain M, Greenberg J, Cataneo RN: Variations in volatile organic compounds in the breath of normal humans. J Chromatogr B 1999;729: 75-88.
6. Turner AP, Magan N: Electronic noses and disease diagnostics. Nat Rev Microbiol 2004;2:161-166.
7. Ropke J, Hannemann M: Special section on breath gas analysis. J Breath Res 2011;5:020201.
8. Wehinger A, Schmid A, Mechtcheriakov S, Ledochowski M, Grbamer C, Gastl GA, Amann A: Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas. Int J Mass Spectrom 2007;265:49-59.
9. Bajtarevic A, Ager C, Pienz M, Klieber M, Schwarz K, Ligor M, Ligor T, Filipiak W, Denz H, Fiegl M, Hilbe W, Weiss W, Lukas P, Jamnig H, Haidenberger A, Buszewski B, Miekisch W, Schubert J, Amann A: Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer 2009;9:348.
10. Greiter MB, Keck L, Siegmund T, Hoeschen C, Oeh U, Paretzke HG: Differences in exhaled gas profiles between patients with type 2 diabetes and healthy controls. Diabetes Technol Ther 2010;12:455-463.
11. Smith D, Španěl P, Fryer AA, Hanna F, Ferns GAA: Can volatile organic compounds in exhaled breath be used to monitor control in diabetes mellitus? J Breath Res 2011;5: 022001.
12. Novak BJ, Blake DR, Meinardi S: Exhaled methyl nitrate as a noninvasive marker of hyperglycemia in type 1 diabetes. Proc Natl Acad Sci U S A 2007;104:15613-15618.
13. Galassetti PR, Noval B, Nemet D, Rose-Gottron C, Cooper DM, Meinardi S, Newcomp R, Zaldivar F, Blake DR: Breath ethanol and acetone as indicators of serum glucose levels: an initial report. Diabetes Technol Ther 2005;7:115-123.
14. Lee J, Ngo J, Blake D, Meinardi S, Pontello AM, Newcomb R, Galassetti PR: Improved predictive models for plasma glucose estimation from multi-linear regression analysis of exhaled volatile organic compounds. J Appl Physiol 2009; 107:155-160.
15. Minh TDC, Oliver SR, Ngo J, Flores R, Midyett J, Meinardi S, Carlson MK, Rowland FS, Blake DR, Galassetti PR: Noninvasive measurement of plasma glucose from exhaled breath in healthy and type 1 diabetic subjects. Am J Physiol Endocrinol Metab 2011;300:E1166-E1175.
16. Pleil JD: Non invasive biomedical analysis. Breath Networking Session at PittCon 2011, Atlanta, Georgia. J Breath Res 2011;5:029001.
17. Kerner W, Brückel J: Definition, Klassifikation und Diagnostik des Diabetes Mellitus. Evidenzbasierte Leitlinie der Deutschen Diabetes-Gesellschaft (DDG). Diabetologie 2011; 6(Suppl 2):S107-S110.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-419.
19. Hansel A, Jordan A, Warneke C, Holzinger R, Wisthaler A, Lindinger W: Proton-transfer-reaction mass spectrometry (PTR-MS): on-line monitoring of volatile organic compounds at volume mixing ratios of a few pptv. Plasma Sources Sci Technol 1999;8:332-336.
20. Herbig J, Titzmann T, Beauchamp J, Kohl I, Hansel A: Buffered end-tidal (BET) sampling - a novel method for realtime breath-gas analysis. J Breath Res 2008;2:03700817.
21. King J, Kupferthaler A, Unterkofler K, Koc H, Teschl S, Teschl G, Miekisch W, Schubert J, Hinterhuber H, Amann A: Isoprene and acetone concentration profiles during exercise on an ergometer. J Breath Res 2009;3:027006.
22. King J, Unterkofler K, Teschl G, Teschl S, Mochalski P, Koc H, Hinterhuber H, Amann A: A modeling-based evaluation of isothermal rebreathing for breath gas analyses of highly soluble volatile organic compounds. J Breath Res 2012;6: 016005.
23. King J, Koc H, Unterkofler K, Mochalski P, Kupferthaler A, Teschl G, Teschl S, Hinterhuber H, Amann A: Physiological modeling of isoprene dynamics in exhaled breath. J Theor Biol 2010;267:626-637.
24. King J, Unterkofler K, Teschl G, Teschl S, Koc H, Hinterhuber H, Amann A: A mathematical model for breath gas analysis of volatile organic compounds with special emphasis on acetone. J Math Biol 2011;63:959-999.
25. Buhr K, Ruth S, Delahunty C: Analysis of volatile flavour compounds by proton transfer reaction-mass spectrometry: fragmentation patterns and discrimination between isobaric and isomeric compounds. Int J Mass Spectrom 2002; 221:1-7.
26. Schwarz K, Filipak W, Amann A: Determination concentration patterns of volatile compounds in exhaled breath by PTR-MS. J Breath Res 2009;3:027002.
27. Schwarz K, Pizzini A, Arendacka B, Zerlauth K, Filipiak W, Schmid A, Dzien A, Neuner S, Lechleitner M, Scholl-Bürgi S, Miekisch W, Schubert J, Unterkofler K, Witkovsky V, Gastl G, Amann A: Breath acetone-aspects of normal physiology related to age and gender as determined in a PTR-MS study. J Breath Res 2009;3:027003.
28. Warneke C, Kuczynski J, Hansel A, Jordan A, Vogel W, Lindinger W: Proton transfer reaction mass spectrometry (PTR-MS): propanol in human breath. Int J Mass Spectrom Ion Process 1996;154:61-70.
29. Kautzky-Willer A, Bancher-Todesca D, Weitgasser R, Prikoszovich T, Steiner H, Shnawa N, Schernthaner G, Birnbacher R, Schneider B, Marth C, Roden M, Lechleitner M: The impact of risk factors and more stringent diagnostic criteria of gestational diabetes on outcomes in central European women. J Clin Endocrinol Metab 2008;93:1689- 1695.
30. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA: Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358: 1991-2002.
31. Kalapos MP: On the mammalian acetone metabolism: from chemistry to clinical implications. Biochim Biophys Acta 2003;1621:122-139.
32. Wijekoon EP, Brosnan ME, Brosnan JT: Homocystein metabolism in diabetes. Biochem Soc Trans 2007;35:1175-1179.
33. Medina-Navarro R, Duran-Reyes G, Diaz-Florez M, Hicks JJ, Kumate J: Glucose-stimulated acrolein production from unsaturated fatty acids. Hum Exp Toxicol 2004;23:101-105.
34. Jagt DLV, Hunsaker LA: Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase- I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase. Chem Biol Interact 2003;143-144:341-351.
35. Lappas M, Hiden U, Desoye G, Froehlich J, Mouzon SH, Jawerbaum A: The role of oxidative stress in the pathophysiology of gestational diabetes mellitus. Antioxid Redox Signal 2011;15:3061-3100.
36. Tate RL, Mehlman MA, Tobin RB: Metabolic fate of 1,3- butanediol in the rat: conversion to β-hydroxybutyrate. J Nutr 1971;101:1719-1726.
37. Blom HJ, Boers GH, Elzen JP, Gahl WA, Tangerman A: Transamination of methionine in humans. Clin Sci 1989; 76:43-49.
38. Scislowski PWD, Pickard K: The regulation of transaminative flux of methionine in rat liver mitochondria. Arch Biochem Biophys 1994;314:412-416.
39. Doisaki M, Katano Y, Nakano I, Hiooka Y, Itoh A, Ishigami M, Hayashi K, Goto H, Fujita Y, Kadoa Y, Kitaura Y, Bajotto G, Kazama S, Tamura T, Tamura N, Feng GG, Ishikawa N, Shimomura Y: Regulation of hepatic branched-chain a-keto acid dehydrogenase kinase in a rat model for type 2 diabetes mellitus at different stages of the disease. Biochem Biophys Res Commun 2010;393:303-307.